MESO
Income statement / Annual
Last year (2025), Mesoblast Limited's total revenue was $17.20 M,
an increase of 191.39% from the previous year.
In 2025, Mesoblast Limited's net income was -$102.14 M.
See Mesoblast Limited,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
| Operating Revenue |
$17.20 M |
$5.90 M |
$7.50 M |
$10.21 M |
$7.46 M |
$32.16 M |
$16.72 M |
$17.34 M |
$2.41 M |
$42.55 M |
| Cost of Revenue |
$5.13 M
|
$41.07 M
|
$54.92 M
|
$63.57 M
|
$85.73 M
|
$81.50 M
|
$75.17 M
|
$5.51 M
|
$12.07 M
|
$29.76 M
|
| Gross Profit |
$12.07 M
|
-$35.17 M
|
-$47.42 M
|
-$53.36 M
|
-$78.28 M
|
-$49.34 M
|
-$58.45 M
|
$11.83 M
|
-$9.65 M
|
$12.79 M
|
| Gross Profit Ratio |
0.7
|
-5.96
|
-6.32
|
-5.23
|
-10.5
|
-1.53
|
-3.5
|
0.68
|
-4
|
0.3
|
| Research and Development Expenses |
$34.81 M
|
$25.35 M
|
$27.19 M
|
$32.82 M
|
$53.01 M
|
$56.19 M
|
$59.82 M
|
$65.93 M
|
$58.91 M
|
$50.01 M
|
| General & Administrative Expenses |
$23.21 M
|
$23.63 M
|
$25.37 M
|
$27.21 M
|
$30.87 M
|
$25.61 M
|
$21.63 M
|
$21.91 M
|
$23.01 M
|
$22.50 M
|
| Selling & Marketing Expenses |
$16.10 M
|
$0.00
|
$27.73 M
|
$30.76 M
|
$32.72 M
|
$25.31 M
|
$15.36 M
|
$5.51 M
|
$12.07 M
|
$29.76 M
|
| Selling, General & Administrative Expenses |
$39.31 M
|
$23.63 M
|
$53.11 M
|
$57.97 M
|
$63.59 M
|
$50.92 M
|
$36.98 M
|
$27.42 M
|
$35.07 M
|
$52.26 M
|
| Other Expenses |
$395.00 K
|
$0.00
|
$0.00
|
$30.76 M
|
$32.65 M
|
$25.23 M
|
$15.48 M
|
-$1.31 M
|
$10.53 M
|
$25.92 M
|
| Operating Expenses |
$74.51 M
|
$48.98 M
|
$76.79 M
|
$90.79 M
|
$115.06 M
|
$107.56 M
|
$97.88 M
|
$92.03 M
|
$92.50 M
|
$98.44 M
|
| Cost And Expenses |
$79.64 M
|
$90.05 M
|
$76.79 M
|
$90.79 M
|
$115.06 M
|
$107.56 M
|
$97.88 M
|
$92.03 M
|
$92.50 M
|
$98.44 M
|
| Interest Income |
$3.55 M
|
$1.82 M
|
$831.00 K
|
$0.00
|
$0.00
|
$542.00 K
|
$719.00 K
|
$366.00 K
|
$468.00 K
|
$1.08 M
|
| Interest Expense |
$22.93 M
|
$20.66 M
|
$19.44 M
|
$17.29 M
|
$10.71 M
|
$14.72 M
|
$11.70 M
|
$1.83 M
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$6.40 M
|
$1.90 M
|
$4.11 M
|
$4.38 M
|
$4.26 M
|
$3.67 M
|
$2.14 M
|
$2.65 M
|
$3.06 M
|
$2.19 M
|
| EBITDA |
-$73.66 M |
-$56.08 M |
-$58.55 M |
-$76.57 M |
-$84.65 M |
-$68.97 M |
-$84.54 M |
-$74.69 M |
-$87.16 M |
-$28.07 M |
| EBITDA Ratio |
-4.28
|
-9.5
|
-7.81
|
-7.5
|
-11.35
|
-2.14
|
-5.06
|
-4.31
|
-36.14
|
-0.66
|
| Operating Income Ratio |
-3.63
|
-14.26
|
-9.24
|
-7.89
|
-14.63
|
-2.33
|
-4.8
|
-4.46
|
-37.33
|
-1.31
|
| Total Other Income/Expenses Net |
-$39.37 M
|
-$4.00 M
|
-$12.81 M
|
-$10.48 M
|
$9.47 M
|
-$12.48 M
|
-$18.34 M
|
$9.24 M
|
-$173.00 K
|
-$34.93 M
|
| Income Before Tax |
-$101.81 M
|
-$88.15 M
|
-$82.10 M
|
-$91.59 M
|
-$99.63 M
|
-$87.36 M
|
-$98.75 M
|
-$65.98 M
|
-$90.22 M
|
-$90.82 M
|
| Income Before Tax Ratio |
-5.92
|
-14.94
|
-10.95
|
-8.97
|
-13.36
|
-2.72
|
-5.91
|
-3.8
|
-37.4
|
-2.13
|
| Income Tax Expense |
$330.00 K
|
-$191.00 K
|
-$212.00 K
|
-$239.00 K
|
-$819.00 K
|
-$9.42 M
|
-$8.96 M
|
-$30.69 M
|
-$13.40 M
|
-$86.69 M
|
| Net Income |
-$102.14 M
|
-$87.96 M
|
-$81.89 M
|
-$91.35 M
|
-$98.81 M
|
-$77.94 M
|
-$89.80 M
|
-$35.29 M
|
-$76.82 M
|
-$4.13 M
|
| Net Income Ratio |
-5.94
|
-14.9
|
-10.92
|
-8.95
|
-13.25
|
-2.42
|
-5.37
|
-2.04
|
-31.85
|
-0.1
|
| EPS |
-0.84 |
-0.89 |
-0.98 |
-1.3 |
-1.6 |
-1.5 |
-1.8 |
-0.76 |
-1.4 |
-0.077 |
| EPS Diluted |
-0.84 |
-0.89 |
-0.98 |
-1.3 |
-1.6 |
-1.5 |
-1.8 |
-0.76 |
-1.4 |
-0.077 |
| Weighted Average Shares Out |
$120.78 M
|
$98.67 M
|
$83.77 M
|
$68.27 M
|
$60.51 M
|
$52.88 M
|
$49.44 M
|
$46.56 M
|
$53.77 M
|
$53.77 M
|
| Weighted Average Shares Out Diluted |
$120.78 M
|
$98.67 M
|
$83.93 M
|
$68.29 M
|
$60.51 M
|
$52.88 M
|
$49.44 M
|
$46.57 M
|
$53.77 M
|
$53.77 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
